Proxima Supper Series

Join us for the Proxima Supper Series, an exclusive gathering where senior healthcare leaders engage in meaningful, off-the-record conversations.

We're excited to partner with Convoke for our inaugural event in San Francisco! The evening's theme will focus on "Moving biopharma at agent speed: what is hype versus what is real in accelerating drug discovery + development with AI."

👤 We'll have the pleasure of welcoming Maged Korga Ahmed, the Founder of Convoke, who brings invaluable insights on this topic.

Space is limited—RSVP today to secure your spot!

About Convoke

Convoke is on a mission to create the AI-native operating system for drug development and to streamline the complex processes involved in launching new drugs.

🧠 Biopharma companies face the challenge of integrating data from numerous sources while engaging hundreds of contributors. This complexity can hinder productivity in the industry.

However, with advancements in machine learning, teams can learn and iterate at the speed of silicon rather than human limitations. Convoke aims to build an autonomous system that leads the way for the next generation of drugs to reach the market. As we innovate in drug development, what will set apart successful programs will be their approach, rather than the chemistry itself.

About Maged Korga Ahmed

Maged is a co-founder of Convoke, backed by renowned investors like Kleiner Perkins and Dimension. His company is already making waves, with its software implemented across top-30 pharma companies and biotechs, empowering teams in both development and commercial sectors. Maged's previous experience includes pivotal roles in the self-driving industry, leading data and AI product initiatives at Applied Intuition, which advanced to become a critical player in automotive software.

📍 Location: 1625 Post St